SFMBT1 and neoplasm: To evaluate tumor formation in vivo at earlier times, we used the zebrafish xenograft model, which showed that Ru1-pre-treated cells gave rise to significantly fewer microtumors at day 6 post-injection (p.i.)(Fig. 1I), when compared with control cells.